Euan Thomson, CEO of Zeiss Meditec, Inc., is passionate about using large-scale collaborations and large-scale sharing of data, with machine learning, to extract insights he says “will really move the needle on healthcare.”In this episode of the OIS Podcast, Thomson and our host Ranya Habash, MD, discuss how the Covid pandemic accelerated the use of telemedicine and remote collaboration, and the trends that may continue going forward. Thomson says artificial intelligence is very logical for use in ophthalmology, due to the number of images used, but also because there is “less of a barrier to entry” for AI here than in some other fields. He also says telehealth will have a role with remote testing and monitoring. Thomson said Zeiss sees digital technologies as the future, both from a device and platform standpoint, and said, “When I think about digital it really is the ability to connect from anywhere, operate in a different way, streamline your workflow, and then ultimately when you do have data at scale and you can figure out new insights from that data, we start to improve patient care in some really big ways.”Click play to hear Euan Thomson talk about how digital technologies and large-scale sharing of data will bring big changes to healthcare.